Cowealth Medical China Co (SHSE:603122) Cash Flow for Dividends: ¥-52.4 Mil (TTM As of Mar. 2026)


SHSE:603122 Cowealth Medical China Co Ltd SHSE:603122
41 GF Score
Price ¥10.26
GF Value ¥3.87
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cowealth Medical China Co Cash Flow for Dividends?

Cowealth Medical China Co SHSE:603122 -0.19% 41 Cash Flow for Dividends is ¥-52.4 Mil as of Mar. 2026. GuruFocus rates SHSE:603122 with a GF Score™ of 41/100 and a GF Value™ of ¥3.87 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Cowealth Medical China Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥-0.7 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-52.4 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Cowealth Medical China Co's quarterly payment of dividends declined from Sep. 2025 (¥-52.4 Mil) to Dec. 2025 (¥1.2 Mil) but then increased from Dec. 2025 (¥1.2 Mil) to Mar. 2026 (¥-0.7 Mil).

Cowealth Medical China Co's annual payment of dividends declined from Dec. 2023 (¥-65.3 Mil) to Dec. 2024 (¥-26.9 Mil) but then increased from Dec. 2024 (¥-26.9 Mil) to Dec. 2025 (¥-52.7 Mil).

Cowealth Medical China Co Cash Flow for Dividends Related Terms

Cowealth Medical China Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Cowealth Medical China Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical China Co Cash Flow for Dividends Chart

Cowealth Medical China Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only -79.65 -74.54 -65.25 -26.95 -52.66

Cowealth Medical China Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.98 -0.47 -52.38 1.17 -0.68
SHSE:603122
41GF Score
Cowealth Medical China Co Ltd SHSE:603122
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical China Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-52.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥-52.4 Mil mean?
Cowealth Medical China Co (SHSE:603122) has a Cash Flow for Dividends of ¥-52.4 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Cowealth Medical China Co and its competitors.
Is Cowealth Medical China Co's Cash Flow for Dividends too high?
Cowealth Medical China Co's current Cash Flow for Dividends is ¥-52.4 Mil. Overall, Cowealth Medical China Co has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical China Co's Cash Flow for Dividends compare to TMO and DHR?
Cowealth Medical China Co's Cash Flow for Dividends of ¥-52.4 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Diagnostics & Research company?
A good Cash Flow for Dividends depends on the Medical Diagnostics & Research industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Cowealth Medical China Co and its competitors. Cowealth Medical China Co's current Cash Flow for Dividends is ¥-52.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical China Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical China Co (SHSE:603122) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.87, compared to a current price of ¥10.26 — trading 165.1% above its estimated fair value. The current Cash Flow for Dividends is ¥-52.4 Mil. Cowealth Medical China Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Cowealth Medical China Co (SHSE:603122), the current Cash Flow for Dividends is ¥-52.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cowealth Medical China Co (SHSE:603122) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical China Co stock appears to be overvalued. The current stock price of ¥10.26 is trading 165.1% above its estimated GF Value™ of ¥3.87. GuruFocus considers Cowealth Medical China Co to be Significantly Overvalued.

Key valuation signals for SHSE:603122:

  • Cash Flow for Dividends: ¥-52.4 Mil
  • GF Value™: ¥3.87 vs. price of ¥10.26 (165.1% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cowealth Medical China Co Business Description

Address No. 1001 Qinzhou North Road, 21st Floor, Building 12, Xuhui District, Shanghai, CHN, 200131
Cowealth Medical China Co Ltd operates as a diagnostic clinical laboratory company. It has introduced radiation oncology technology into the market.
41GF Score

Get the complete analysis for SHSE:603122

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.26
Price
¥3.87
GF Value